Bioperfectus sets out for post-pandemic daily surveillance: COVID-19 Antigen Rapid Test included in the EU Common List

Company news

We Bioperfectus are glad to announce that our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit has been included in the EU Health Security Committee common list of COVID-19 rapid antigen tests.


The detection capacity of Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit for the SARS-CoV-2 mutation lineages (B.1.1.7, B.1.351, B.1.617.1 and P.1) has also been validated. Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit can detect SARS-CoV-2 within 15 minutes and compatible with specimens of nasal swab, nasopharyngeal swab and oropharyngeal swab. With package of 1, 2, 5, 10, 15, 20, 25, 50 Tests/Kit, our kits provide flexible options to fulfill different clinical throughput requirements.



Empowering Women's Health: Gynecologic Cancer Awareness Month

September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.


Academy Express | Human Papillomavirus (HPV) Infection and Its Impact on Male Infertility

HPV semen infection, regardless of HPV type and exact location of the virions, significantly impairs spermatozoa’s progressive motility, morphology, and immotile sperm rate.


World Sexual Health Day 2023: Empowering Sexual Well-being

Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.